AVBP – arrivent biopharma, inc. (US:NASDAQ)
Stock Stats
News
ArriVent BioPharma Reports Full Year 2025 Financial Results [Yahoo! Finance]
ArriVent BioPharma Reports Full Year 2025 Financial Results
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
$207B Market Shift: The Race for Fast Track Approval in Oncology
Form S-8 ArriVent BioPharma, Inc.
Form 10-K ArriVent BioPharma, Inc. For: Dec 31
Form 8-K ArriVent BioPharma, Inc. For: Mar 05
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Sofinnova Venture Partners IX, L.P.
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: INFINITUM ASSET MANAGEMENT, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.